Found: 119
Select item for more details and to access through your institution.
Managing and containing Clostridium difficile disease.
- Published in:
- Patient Care (Print), 1998, v. 32, n. 7, p. 171
- By:
- Publication type:
- Article
Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 6, p. 1, doi. 10.1093/ofid/ofaa157
- By:
- Publication type:
- Article
1496. Bezlotoxumab Administered at the End of a Suppressive Drug Regimen for Patients with Multiply Recurrent Clostridioides difficile Infection.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S545, doi. 10.1093/ofid/ofz360.1360
- By:
- Publication type:
- Article
LB5. A Long-Time Coming: Final 2-year Analysis of Efficacy, Durability, and Microbiome Changes in a Controlled Open-Label Trial of Investigational Microbiota-Based Drug RBX2660 for Recurrent Clostridioides difficile Infections.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S994, doi. 10.1093/ofid/ofz415.2488
- By:
- Publication type:
- Article
2565. Initial and Recurrent Episodes of Clostridioides difficile: Online Education as a Tool to Improve Management Strategies.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S891, doi. 10.1093/ofid/ofz360.2243
- By:
- Publication type:
- Article
Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes.
- Published in:
- Open Forum Infectious Diseases, 2016, v. 3, n. 1, p. 1, doi. 10.1093/ofid/ofv196
- By:
- Publication type:
- Article
Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies.
- Published in:
- Open Forum Infectious Diseases, 2014, v. 1, n. 2, p. 1, doi. 10.1093/ofid/ofu069
- By:
- Publication type:
- Article
Epidemiology of Community-Associated Clostridium difficile Infection, 2009 Through 2011.
- Published in:
- JAMA Internal Medicine, 2013, v. 173, n. 14, p. 1359, doi. 10.1001/jamainternmed.2013.7056
- By:
- Publication type:
- Article
Concomitant Medical Conditions and Therapies Preclude Accurate Classification of Children With Severe or Severe Complicated Clostridium difficile Infection.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2015, v. 4, n. 4, p. e139, doi. 10.1093/jpids/piu121
- By:
- Publication type:
- Article
Unique Clindamycin-Resistant Clostridioides difficile Strain Related to Fluoroquinolone-Resistant Epidemic BI/RT027 Strain.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Multihospital Outbreak of Clostridium difficile Infection, Cleveland, Ohio, USA.
- Published in:
- Emerging Infectious Diseases, 2010, v. 16, n. 5, p. 827, doi. 10.3201/eid1605.071606
- By:
- Publication type:
- Article
The Relative Role of Toxins A and B in the Virulence of Clotridioides difficile.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 1, p. 96, doi. 10.3390/jcm10010096
- By:
- Publication type:
- Article
Effect of the COVID-19 Pandemic on Rates and Epidemiology of Clostridioides difficile Infection in One VA Hospital.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 7, p. 1159, doi. 10.3390/antibiotics12071159
- By:
- Publication type:
- Article
Toxinotype V Clostridium difficile in Humans and Food Animals.
- Published in:
- Emerging Infectious Diseases, 2008, v. 14, n. 7, p. 1039, doi. 10.3201/eid1407.071641
- By:
- Publication type:
- Article
Letters.
- Published in:
- 1994
- By:
- Publication type:
- Letter
Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Disease associated with Clostridium difficile infection.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Binary Toxin-Producing, Large Clostridial Toxin-Negative Clostridium difficile Strains Are Enterotoxic but Do Not Cause Disease in Hamsters.
- Published in:
- Journal of Infectious Diseases, 2006, v. 193, n. 8, p. 1143, doi. 10.1086/501368
- By:
- Publication type:
- Article
Prevention of Fatal Clostridium difficile--Associated Disease during Continuous Administration of Clindamycin in Hamsters.
- Published in:
- Journal of Infectious Diseases, 2003, v. 188, n. 12, p. 1922, doi. 10.1086/379836
- By:
- Publication type:
- Article
Colonization for the Prevention of Clostridium difficile Disease in Hamsters.
- Published in:
- Journal of Infectious Diseases, 2002, v. 186, n. 12, p. 1781, doi. 10.1086/345676
- By:
- Publication type:
- Article
Infection of Hamsters with Epidemiologically Important Strains of Clostridium difficile.
- Published in:
- Journal of Infectious Diseases, 2001, v. 183, n. 12, p. 1760, doi. 10.1086/320736
- By:
- Publication type:
- Article
Wide Diversity Of Clostridium Difficile Types At A Tertiary Referral Hospital.
- Published in:
- Journal of Infectious Diseases, 1994, v. 170, n. 3, p. 615
- By:
- Publication type:
- Article
Systemic and Mucosal Antibody Responses to Toxin A in Patients Infected with Clostridium difficile.
- Published in:
- Journal of Infectious Diseases, 1992, v. 166, n. 6, p. 1287, doi. 10.1093/infdis/166.6.1287
- By:
- Publication type:
- Article
Acquisition of Clostridium difficile by Hospitalized Patients: Evidence for Colonized New Admissions as a Source of Infection.
- Published in:
- Journal of Infectious Diseases, 1992, v. 166, n. 3, p. 561, doi. 10.1093/infdis/166.3.561
- By:
- Publication type:
- Article
gyrA Mutations in Ciprofloxacin-Resistant, Methicillin-Resistant Staphylococcus aureus from Indiana, Minnesota, and Tennessee.
- Published in:
- Journal of Infectious Diseases, 1991, v. 164, n. 5, p. 976, doi. 10.1093/infdis/164.5.976
- By:
- Publication type:
- Article
Intravenous Metronidazole and Clostridium difficile—Associated Diarrhea or Colitis.
- Published in:
- Journal of Infectious Diseases, 1989, v. 160, n. 6, p. 1087
- By:
- Publication type:
- Article
Host Immune Responses to Clostridioides difficile : Toxins and Beyond.
- Published in:
- Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.804949
- By:
- Publication type:
- Article
Antibiotic Concentration in Ascitic Fluid of Patients with Ascites and Bacterial Peritonitis.
- Published in:
- Annals of Internal Medicine, 1977, v. 86, n. 6, p. 708, doi. 10.7326/0003-4819-86-6-708
- By:
- Publication type:
- Article
Spore Formation and Toxin Production in <i>Clostridium difficile</i> Biofilms.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0087757
- By:
- Publication type:
- Article
A Simulation-Based Assessment of Strategies to Control <i>Clostridium Difficile</i> Transmission and Infection.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0080671
- By:
- Publication type:
- Article
Surface-Layer Protein A (SlpA) Is a Major Contributor to Host-Cell Adherence of <i>Clostridium difficile</i>.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0078404
- By:
- Publication type:
- Article
Vaccination With Parenteral Toxoid B Protects Hamsters Against Lethal Challenge With Toxin A-Negative, Toxin B-Positive Clostridium difficile but Does Not Prevent Colonization.
- Published in:
- Journal of Infectious Diseases, 2012, v. 205, n. 1, p. 128, doi. 10.1093/infdis/jir688
- By:
- Publication type:
- Article
Infection of Hamsters with Historical and Epidemic BI Types of Clostridium difficile.
- Published in:
- Journal of Infectious Diseases, 2007, v. 196, n. 12, p. 1813, doi. 10.1086/523106
- By:
- Publication type:
- Article
Toxin B is essential for virulence of Clostridium difficile.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Fatal Pseudomembranous Colitis Associated with a Variant Clostridium difficile Strain Not Detected by Toxin A Immunoassay.
- Published in:
- Annals of Internal Medicine, 2001, v. 135, n. 6, p. 434, doi. 10.7326/0003-4819-135-6-200109180-00012
- By:
- Publication type:
- Article
Activity of Twenty-One Antimicrobial Agents Including /-Ofloxacin against Quinolone-Sensitive and -Resistant, and Methicillin-Sensitive and -Resistant Staphylococcus aureus.
- Published in:
- Chemotherapy (0009-3157), 1994, v. 40, n. 1, p. 21, doi. 10.1159/000239165
- By:
- Publication type:
- Article
Incidence and Outcome of Clostridium difficile Infection—Beware of Strain Type and Diagnostic Tests.
- Published in:
- 2020
- By:
- Publication type:
- Opinion
Efficacy of Bezlotoxumab in Trial Participants Infected With Clostridioides difficile Strain BI Associated With Poor Outcomes.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 9, p. e2616, doi. 10.1093/cid/ciaa1035
- By:
- Publication type:
- Article
A Tapered-pulsed Fidaxomicin Regimen Following Treatment in Patients With Multiple Clostridioides difficile Infection Recurrences.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 6, p. 1107, doi. 10.1093/cid/ciab233
- By:
- Publication type:
- Article
Guideline Recommendations: Optimal Timing of Publication and Resulting Rate of Adoption.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile Infection.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 1, p. 81, doi. 10.1093/cid/ciz809
- By:
- Publication type:
- Article
Toxin A–Predominant Pathogenic Clostridioides difficile: A Novel Clinical Phenotype.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 12, p. 2628, doi. 10.1093/cid/ciz727
- By:
- Publication type:
- Article
Natural Clostridioides difficile Toxin Immunization in Colonized Infants.
- Published in:
- Clinical Infectious Diseases, 2020, v. 79, n. 10, p. 2095, doi. 10.1093/cid/ciz582
- By:
- Publication type:
- Article
Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 10, p. 1667, doi. 10.1093/cid/ciz009
- By:
- Publication type:
- Article
Bezlotoxumab.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 4, p. 699, doi. 10.1093/cid/ciy577
- By:
- Publication type:
- Article
Reply to Fabre et al.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 12, p. 1958, doi. 10.1093/cid/ciy475
- By:
- Publication type:
- Article
Reply to Million et al.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 11, p. 1799, doi. 10.1093/cid/ciy460
- By:
- Publication type:
- Article
Reply to Collins and Riley.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 10, p. 1640, doi. 10.1093/cid/ciy251
- By:
- Publication type:
- Article
Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660—A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 8, p. 1198, doi. 10.1093/cid/ciy259
- By:
- Publication type:
- Article